Pharma IT Insights
Changes and Additions in the New Eudralex vol. 4, Chapter 4: Documentation
By Torben Elhauge
July 1, 2026
Pharma IT Insights
Changes and Additions in the New Eudralex vol. 4, Chapter 4: Documentation
By Torben Elhauge
July 1, 2026
The regulatory landscape for GMP documentation is evolving rapidly.
The new Chapter 4 introduces wider scope, tighter integrity controls, and explicit references to Annex 11(computerised systems), Annex 22 (AI use in GMP), and Chapter 6 (QC – the part regarding sampling and testing) is referenced.
This insight outlines the main additions, structural changes, and practical steps companies should take to ensure compliance with the updated text.
What is the new Chapter 4 about?
The revision strengthens documentation control across the entire pharmaceutical data life cycle by introducing Data governance, risk assessment and ALCOA++.
How can companies ensure compliance with the new Chapter 4?
- Review and update SOPs for all documentation types to reflect the changes in chapter 4 including Annex 11, Annex 22 and Chapter 6 references.
- Consider including a Data Governance Policy in your system.
- Embed governance, ownership, and risk assessment processes into all relevant processes in your quality system.
- Validate hybrid system and configure electronic systems for trend analysis.
- Update your signature policies defining when to sign manually and electronically both on a policy and practical level.
- Update your data integrity policy introducing ALCOA++ principles across all GMP documentation activities.
The following new chapters have been introduced:
- Data governance systems to include QRM principles and oversee the life cycle of GMP records.
- Risk management linked to the full life cycle of documentation with special focus on challenges with electronic data storage.
- General requirements with special focus on hybrid systems, outsourced functions, annex 11 and annex 22. It is stressed that you are responsible for AI generated data and electronic systems must support trending. Avoid defining printed data as raw data.
- Master Documents combine “Required GMP Documentation” and “Procedures and Records”. Validation master plan and quality agreement have been added. OOS have been separated from Deviations
- Signature in relevant documentation again with focus on electronic systems. It is not allowed to print and manually sign documentation. It is recommended to avoid Hybrid systems, and if used, the signature form should be defined.
- Data Integrity in documentation introducing a more risk-based approach for integrity documentation
- Hybrid systems should be described in detail, and all elements must be validated
- Glossary – was missing earlier make sure to align definitions given with your quality system.
In the existing chapters especially the implementation of ALCOA++ data integrity criteria is a major change. Additionally, the section about retention of documentation have become clearer, again focusing on electronic data. As an example, it is stated that it should be in a human readable format. Additional receipt requirements, including proof of temperature compliance during transport have been added.
How do the changes affect GMP compliance?
- Expanded scope: Must address governance, risk management, hybrid systems, glossary, and AI‑generated data.
- Regulatory cross‑references: Sampling/testing procedures explicitly link to EU GMP Chapter 6, electronic and hybrid systems requirements tied to Annex 11, and if AI is used it is linked to Annex 22.
- Enhanced integrity measures: ALCOA++ must comply and how to sign should be documented in a more controlled manner.
ALCOA++?
ALCOA++ is now embedded in the new Chapter 4 as the benchmark for GMP documentation quality and integrity, with defined attributes:
- Attributable
- Legible
- Contemporaneous
- Original
- Accurate
- Complete
- Consistent
- Enduring
- Available
- Traceable
It applies equally to paper, hybrid, and electronic systems, forming the foundation for all record creation, change control, and retention requirements.
Final thoughts
The revised Chapter 4 expands the requirements for GMP documentation by introducing stronger expectations around data governance, risk management, data integrity, and electronic systems. Organizations should review the new requirements and assess whether their documentation processes, quality systems, and electronic solutions align with the updated expectations.
💡Want to learn more?
If you would like to strengthen your GMP knowledge, explore our GMP Basic Training:
If you need support understanding how the revised Chapter 4 impacts your organization—or help implementing the necessary changes—our GMP consultants are here to help. Feel free to get in touch to discuss how we can support your compliance journey.
About the author
Torben Elhauge is Director of CMC in Pharma IT and Experienced pharmaceutical professional with 25+ years in analytical chemistry, API development, and regulatory documentation. Skilled in project management, workshop facilitation, and RFP processes, with extensive work coordinating CRO/CMO collaborations and tech transfers. Combines deep API knowledge with the ability to translate scientific needs into clear requirements and drive successful platform selection and process improvement projects.


